Related Experiment Video

Updated: Feb 25, 2026

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas
09:21

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas

Published on: September 13, 2019

7.6K

Olaratumab for the treatment of soft-tissue sarcoma

Alexandra Pender1, Robin L Jones1,2

  • 1Sarcoma Unit, Department of Medicine, The Royal Marsden NHS Foundation Trust, London, UK.

Future Oncology (London, England)
|July 27, 2017
PubMed

Insights

Olaratumab, combined with doxorubicin, offers a new treatment option for unresectable soft tissue sarcoma, improving overall survival in patients previously untreated with anthracyclines.

Area of Science:

  • Oncology
  • Medical Oncology
  • Sarcoma Research

Background:

  • Soft tissue sarcoma (STS) has a poor prognosis in advanced stages.
  • Current first-line treatments lack significant survival benefits.

Purpose of the Study:

  • To review preclinical and clinical data for olaratumab in sarcoma.
  • To discuss the Phase Ib/II trial results and ongoing studies of olaratumab.

Main Methods:

  • Review of preclinical studies and early clinical data.
  • Analysis of a Phase Ib/randomized Phase II trial comparing doxorubicin with or without olaratumab.
  • Discussion of ongoing clinical trials.

Main Results:

  • A Phase Ib/II trial showed improved median overall survival with olaratumab plus doxorubicin.
  • This combination led to regulatory approval for specific STS patient populations.

Conclusions:

  • Olaratumab represents a significant advancement in first-line treatment for unresectable STS.
  • Further trials are evaluating olaratumab's role in various sarcoma settings.
Keywords:
PDGFR-αolaratumabsarcomas

More Related Videos

Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model13:41

Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model

Published on: January 13, 2023

2.9K
Targeted and Selective Treatment of Pluripotent Stem Cell-derived Teratomas Using External Beam Radiation in a Small-animal Model05:08

Targeted and Selective Treatment of Pluripotent Stem Cell-derived Teratomas Using External Beam Radiation in a Small-animal Model

Published on: February 17, 2019

6.7K

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K